Table of Contents
ISRN Neuroscience
Volume 2013 (2013), Article ID 170316, 4 pages
http://dx.doi.org/10.1155/2013/170316
Research Article

Traveled Distance Is a Sensitive and Accurate Marker of Motor Dysfunction in a Mouse Model of Multiple Sclerosis

1Medical Research Institute, Tokyo Women’s Medical University, Tokyo 162-8666, Japan
2Kita Medical and Rehabilitation Center for Disabled, Tokyo 114-0033, Japan

Received 27 September 2013; Accepted 14 November 2013

Academic Editors: C. Comi, E. M. Mowry, and M. Sasaki

Copyright © 2013 Takako Takemiya and Chisen Takeuchi. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. H. Noseworthy, C. Lucchinetti, M. Rodriguez, and B. G. Weinshenker, “Multiple sclerosis,” The New England Journal of Medicine, vol. 343, no. 13, pp. 938–952, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. I. Mendel, N. Kerlero de Rosbo, and A. Ben-Nun, “A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor Vβ expression of encephalitogenic T cells,” European Journal of Immunology, vol. 25, no. 7, pp. 1951–1959, 1995. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Iglesias, J. Bauer, T. Litzenburger, A. Schubart, and C. Linington, “T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis,” GLIA, vol. 36, no. 2, pp. 220–234, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Takeuchi, Y. Matsumoto, K. Kohyama et al., “Microsomal prostaglandin E synthase-1 aggravates inflammation and demyelination,” Neurochemistry International, vol. 62, pp. 271–280, 2013. View at Google Scholar
  5. Y. Matsumoto and M. Fujiwara, “The immunopathology of adoptively transferred experimental allergic encephalomyelitis (EAE) in Lewis rats. Part I. Immunohistochemical examination of developing lesions of EAE,” Journal of the Neurological Sciences, vol. 77, no. 1, pp. 35–47, 1987. View at Google Scholar · View at Scopus
  6. R. H. Swanborg, “Experimental allergic encephalomyelitis,” Methods in Enzymology, vol. 162, pp. 413–421, 1988. View at Google Scholar · View at Scopus
  7. I. M. Stromnes and J. M. Goverman, “Active induction of experimental allergic encephalomyelitis,” Nature Protocols, vol. 1, no. 4, pp. 1810–1819, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. I. M. Stromnes and J. M. Goverman, “Passive induction of experimental allergic encephalomyelitis,” Nature Protocols, vol. 1, no. 4, pp. 1952–1960, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. I. Tsunoda, L.-Q. Kuang, N. D. Tolley, J. L. Whitton, and R. S. Fujinami, “Enhancement of experimental allergic encephalomyelitis (EAE) by DNA immunization with myelin proteolipid protein (PLP) plasmid DNA,” Journal of Neuropathology and Experimental Neurology, vol. 57, no. 8, pp. 758–767, 1998. View at Google Scholar · View at Scopus
  10. A. Kalyvas and S. David, “Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease,” Neuron, vol. 41, pp. 323–335, 2004. View at Google Scholar
  11. Y. Kihara, T. Matsushita, Y. Kita et al., “Targeted lipidomics reveals mPGES-1-PGE2 as a therapeutic target for multiple sclerosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 51, pp. 21807–21812, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. R. A. Sobel, V. K. Tuohy, Z. Lu, R. A. Laursen, and M. B. Lees, “Acute experimental allergic encephalomyelitis in SJL/J mice induced by a synthetic peptide of myelin proteolipid protein,” Journal of Neuropathology and Experimental Neurology, vol. 49, no. 5, pp. 468–479, 1990. View at Google Scholar · View at Scopus
  13. M. K. Storch, A. Stefferl, U. Brehm et al., “Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology,” Brain Pathology, vol. 8, no. 4, pp. 681–694, 1998. View at Google Scholar · View at Scopus
  14. Y. Pollak, H. Ovadia, I. Goshen et al., “Behavioral aspects of experimental autoimmune encephalomyelitis,” Journal of Neuroimmunology, vol. 104, no. 1, pp. 31–36, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Pollak, H. Ovadia, E. Orion, and R. Yirmiya, “The EAE-associated behavioral syndrome: II. Modulation by anti-inflammatory treatments,” Journal of Neuroimmunology, vol. 137, no. 1-2, pp. 100–108, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Greter, F. L. Heppner, M. P. Lemos et al., “Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis,” Nature Medicine, vol. 11, no. 3, pp. 328–334, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Matejuk, C. Hopke, A. A. Vandenbark, P. D. Hurn, and H. Offner, “Middle-age male mice have increased severity of experimental autoimmune encephalomyelitis and are unresponsive to testosterone therapy,” Journal of Immunology, vol. 174, no. 4, pp. 2387–2395, 2005. View at Google Scholar · View at Scopus
  18. J. L. Croxford, S. Miyake, Y.-Y. Huang, M. Shimamura, and T. Yamamura, “Invariant Vα19i T cells regulate autoimmune inflammation,” Nature Immunology, vol. 7, no. 9, pp. 987–994, 2006. View at Publisher · View at Google Scholar · View at Scopus